Related references
Note: Only part of the references are listed.Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
Steven A. Yukl et al.
AIDS (2010)
Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy
D. McMahon et al.
CLINICAL INFECTIOUS DISEASES (2010)
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Maria J. Buzon et al.
NATURE MEDICINE (2010)
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
Rajesh T. Gandhi et al.
PLOS MEDICINE (2010)
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control
April L. Ferre et al.
BLOOD (2009)
Incomplete Peripheral CD4+ Cell Count Restoration in HIV-Infected Patients Receiving Long-Term Antiretroviral Treatment
Colleen F. Kelley et al.
CLINICAL INFECTIOUS DISEASES (2009)
Detection of HIV-1 in alternative specimen types using the APTIMA® HIV-1 RNA Qualitative Assay
C. Thomas Nugent et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral Therapy
Hiroyu Hatano et al.
JOURNAL OF VIROLOGY (2009)
HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
Maud Mavigner et al.
PLOS ONE (2009)
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
J. B. Dinoso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CD4+count and risk of non-AIDS diseases following initial treatment for HIV infection
Jason V. Baker et al.
AIDS (2008)
Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia
Flavien Bernardin et al.
HEPATOLOGY (2008)
Collagen deposition limits immune reconstitution in the gut
Jacob Estes et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy
Florencia Pereyra et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy
Tae-Wook Chun et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Magnitude and Complexity of Rectal Mucosa HIV-1-Specific CD8+T-Cell Responses during Chronic Infection Reflect Clinical Status
J. William Critchfield et al.
PLOS ONE (2008)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
Lewis H. Kuller et al.
PLOS MEDICINE (2008)
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection
J. William Critchfield et al.
JOURNAL OF VIROLOGY (2007)
Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon-G and interleukin-2 and have a CD8+ cell early maturational phenotype
Elizabeth Sinclair et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms
Tzong-Hae Lee et al.
TRANSFUSION (2006)
Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells
JR Bailey et al.
JOURNAL OF VIROLOGY (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response
DM Moore et al.
AIDS (2006)
Phenotypic, functional, and kinetic parameters associated with a apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment
B Emu et al.
JOURNAL OF VIROLOGY (2005)
Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection
SG Deeks et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury
TH Lee et al.
TRANSFUSION (2005)
Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART
RE Nettles et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy
SR Ostrowski et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
JM Brenchley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation
MR Betts et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years
DV Havlir et al.
JOURNAL OF VIROLOGY (2003)
Optimization of methods to assess human mucosal T-cell responses to HIV infection
BL Shacklett et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover
KB Anthony et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects
PA Anton et al.
AIDS (2003)
Share Paper
